Amphastar Pharmaceuticals (AMPH) Deferred Taxes (2013 - 2021)

Amphastar Pharmaceuticals has reported Deferred Taxes for 5 years, with the latest figure at $2.8 million in Q4 2021.

• On a quarterly basis, Deferred Taxes fell 26.79% year-over-year to $2.8 million in Q4 2021; TTM through Dec 2021 was $4.6 million, a 2728.4% increase from a year earlier, with the FY2025 full-year figure at -$28.7 million, down 260.36% from the prior year.
• Deferred Taxes was $2.8 million for Q4 2021 at Amphastar Pharmaceuticals, down from $3.8 million in the prior quarter.
• The five-year high for Deferred Taxes was $5.3 million in Q4 2019, with the low at -$2.0 million in Q3 2020.
• Average Deferred Taxes over 3 years is $1.7 million, with a median of $2.8 million recorded in 2021.
• The sharpest annual moves came in 2020 and 2021: Deferred Taxes fell 28.71% in 2020, then fell 26.79% in 2021.
• Over 3 years, Deferred Taxes stood at $5.3 million in 2019, then dropped by 28.71% to $3.8 million in 2020, then slipped by 26.79% to $2.8 million in 2021.
• The last three Deferred Taxes figures came in at $2.8 million (Q4 2021), $3.8 million (Q4 2020), and -$2.0 million (Q3 2020), per Business Quant data.